Research Coverage on Small and Micro-Cap Companies, Zacks Small Cap Research

Zacks Small Cap Research

Zacks Small Cap Research provides research coverage on small- and micro-cap companies that are “under-followed” or “under-valued” by Wall Street. We produce high quality equity research for the institutional and retail investor on microcap firms we believe are well positioned for future growth. The Zacks SCR analyst team has an average of 20 years of experience in investment research. We conduct significant due diligence in an effort to maintain the highest quality small-cap universe.

Research Coverage on Small and Micro-Cap Companies

Equity Bottom-Up

<ul><li>On June 4, 2026, Imunon, Inc. (IMNN) announced a financing that is expected to provide up to $10 million in aggregate proceeds.</li><li>The financing includes 250 shares of non-redeemable, non-convertible preferred stock for $2.5 million and two secured promissory notes in the principal amounts of $2.72 million and $5.0 million.</li><li>Importantly, there are no warrants or other dilutive overhangs.</li></ul>

On June 4, 2026, Imunon, Inc. (IMNN) announced a financing that is expected to provide up to $10 million in aggregate proceeds.The financing includes 250 shares of non-redeemable, non-convertible preferred stock for $2.5 million and two secured promissory notes in the principal amounts of $2.72 million and $5.0 million.Importantly, there are no warrants or other dilutive overhangs.

IMNN: 10 Million Financing to Advance Phase 3 OVATION 3 Trial